JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Improving Adherence to Growth Hormone (GH) Therapy via EasypodTM May Help Maximize the Treatment Outcome
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Improving Adherence to Growth Hormone (GH) Therapy via EasypodTM May Help Maximize the Treatment Outcome
Choi, Hae-Jeong;
  PDF(new window)
 Abstract
In Growth Hormone (GH) therapy, suboptimal adherence is a common problem, reaching up to 82%, and there is a need for interventions to improve adherence and to maximize patients` growth potential eventually. Current studies have demonstrated the association between the rate of non-adherence and reduced height velocity. In order to maximize patients` potential to grow, an auto-injecting/recording device, such as , may help improve adherence and optimize the treatment effects of GH therapy. The use of has contributed to high adherence rates: 87.5% and 93% in Bozzola et al.`s study and the Connect Observational study (ECOS), respectively. Improvement of adherence by may lead to higher growth rates of patients receiving GH therapy. Additionally, patients` positive acceptability of suggests is a preferred device by patients for better adherence.
 Keywords
Automatic injector device;GH therapy;Adherence;;
 Language
English
 Cited by
 References
1.
World Health Organisation. Adherence to long-term therapies - Evidence for action. 2003.

2.
Fisher BG, Acerini CL. Understanding the Growth Hormone Therapy Adherence Paradigm: A Systematic Review. Horm Res Paediatr 2013;79:189-96. crossref(new window)

3.
Cutfield WS, et al. Non-compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth. PLos ONE. 2011;6:e16223. crossref(new window)

4.
$Saizen^{(R)}$ Summary of Product Characteristic.

5.
Matsui DM. Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 1997;44:1-14. crossref(new window)

6.
Bozzola M, et al. Treatment adherence with the $easypod^{TM}$ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents. BMC Endocrine Disorders 2011;11:4. crossref(new window)

7.
Dahlgren J, et al. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Curr Med Res Opin. 2007;23:1649-55. crossref(new window)

8.
Aydin B, et al. Adherence to Growth Hormone Therapy: Results of a Multicenter Study. Endocrine Practice. 2014;20:46-51. crossref(new window)

9.
Kapoor RR, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child.2008;93:147-8. crossref(new window)

10.
Davis P, et al. The $Easypod^{TM}$ Connect Observational Study (ECOS): Results from the 2014 Interim Analysis. Endocrine Society's 97th Annual Meeting, March 2015. THR-160 (Meeting Abstract).